13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market
13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
  1. Home
  2. Insider Trading
  3. Curran Terrie

Curran Terrie

CIK: 0001690298•President and Chief Executive
OfficerDirector
Primary company: CELGENE CORP /DE/ (CELG)

Curran Terrie is a corporate insider (President and Chief Executive) at CELGENE CORP /DE/ (CELG) filing SEC Form 4 transactions. 126 transactions across 4 companies, totaling $252,861 in purchases and $4,044,247 in sales. Source: SEC EDGAR.

Total Transactions
126
Total Buy Value
$253K
Total Sell Value
$4.04M
Net Activity
$-3.79M
Last Transaction
Jun 2025
Companies
4

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Company
Type
Shares
Price
Value
Shares After
Date
SEC
Arcutis Biotherapeutics, Inc.
ARQT
Award16,667$21.23$354K16,667
6/5/2026
Filed: 6/5/2026
Filing →
Arcutis Biotherapeutics, Inc.
ARQT
Award5,778--23,526
6/5/2026
Filed: 6/5/2026
Filing →
Arcutis Biotherapeutics, Inc.
ARQT
Award20,568--20,568
6/12/2025
Filed: 6/16/2025
Filing →
Arcutis Biotherapeutics, Inc.
ARQT
Award7,609--17,748
6/12/2025
Filed: 6/16/2025
Filing →
Phathom Pharmaceuticals, Inc.
PHAT
Award342,500$5.76$1.97M342,500
2/27/2025
Filed: 3/3/2025
Filing →
Phathom Pharmaceuticals, Inc.
PHAT
Sale19,109$6.59$126K360,465
1/21/2025
Filed: 1/23/2025
Filing →
Arcutis Biotherapeutics, Inc.
ARQT
Sale8,687$10.85$94K10,139
11/11/2024
Filed: 11/13/2024
Filing →
Phathom Pharmaceuticals, Inc.
PHAT
Sale33,848$11.72$397K377,734
7/15/2024
Filed: 7/17/2024
Filing →
Arcutis Biotherapeutics, Inc.
ARQT
Award27,052--27,052
6/14/2024
Filed: 6/18/2024
Filing →
Arcutis Biotherapeutics, Inc.
ARQT
Award10,139--18,826
6/14/2024
Filed: 6/18/2024
Filing →
Phathom Pharmaceuticals, Inc.
PHAT
Sale16,851$9.11$154K410,784
3/22/2024
Filed: 3/26/2024
Filing →
Phathom Pharmaceuticals, Inc.
PHAT
Award475,000--475,000
1/18/2024
Filed: 1/22/2024
Filing →
Phathom Pharmaceuticals, Inc.
PHAT
Award37,500$0.00$0427,171
11/1/2023
Filed: 11/3/2023
Filing →
Phathom Pharmaceuticals, Inc.
PHAT
Disposition225,000--0
7/14/2023
Filed: 7/17/2023
Filing →
Phathom Pharmaceuticals, Inc.
PHAT
Disposition175,000--0
7/14/2023
Filed: 7/17/2023
Filing →
Phathom Pharmaceuticals, Inc.
PHAT
Award200,000--389,671
7/14/2023
Filed: 7/17/2023
Filing →
Arcutis Biotherapeutics, Inc.
ARQT
Award12,220$0.00$012,220
5/31/2023
Filed: 6/2/2023
Filing →
Arcutis Biotherapeutics, Inc.
ARQT
Award4,375$0.00$08,687
5/31/2023
Filed: 6/2/2023
Filing →
Phathom Pharmaceuticals, Inc.
PHAT
Purchase12,919$7.82$101K188,290
4/6/2023
Filed: 4/7/2023
Filing →
Myovant Sciences Ltd.
MYOV
Disposition21,096--0
3/10/2023
Filed: 3/10/2023
Filing →
Arcutis Biotherapeutics, Inc.
ARQT
Type
Award
Shares
16,667
Price
$21.23
Value
$354K
Arcutis Biotherapeutics, Inc.
ARQT
Type
Award
Shares
5,778
Price
-
Value
-
Arcutis Biotherapeutics, Inc.
ARQT
Type
Award
Shares
20,568
Price
-
Value
-
Arcutis Biotherapeutics, Inc.
ARQT
Type
Award
Shares
7,609
Price
-
Value
-
Phathom Pharmaceuticals, Inc.
PHAT
Type
Award
Shares
342,500
Price
$5.76
Value
$1.97M
Phathom Pharmaceuticals, Inc.
PHAT
Type
Sale
Shares
19,109
Price
$6.59
Value
$126K
Arcutis Biotherapeutics, Inc.
ARQT
Type
Sale
Shares
8,687
Price
$10.85
Value
$94K
Phathom Pharmaceuticals, Inc.
PHAT
Type
Sale
Shares
33,848
Price
$11.72
Value
$397K
Arcutis Biotherapeutics, Inc.
ARQT
Type
Award
Shares
27,052
Price
-
Value
-
Arcutis Biotherapeutics, Inc.
ARQT
Type
Award
Shares
10,139
Price
-
Value
-
Phathom Pharmaceuticals, Inc.
PHAT
Type
Sale
Shares
16,851
Price
$9.11
Value
$154K
Phathom Pharmaceuticals, Inc.
PHAT
Type
Award
Shares
475,000
Price
-
Value
-
Phathom Pharmaceuticals, Inc.
PHAT
Type
Award
Shares
37,500
Price
$0.00
Value
$0
Phathom Pharmaceuticals, Inc.
PHAT
Type
Disposition
Shares
225,000
Price
-
Value
-
Phathom Pharmaceuticals, Inc.
PHAT
Type
Disposition
Shares
175,000
Price
-
Value
-
Phathom Pharmaceuticals, Inc.
PHAT
Type
Award
Shares
200,000
Price
-
Value
-
Arcutis Biotherapeutics, Inc.
ARQT
Type
Award
Shares
12,220
Price
$0.00
Value
$0
Arcutis Biotherapeutics, Inc.
ARQT
Type
Award
Shares
4,375
Price
$0.00
Value
$0
Phathom Pharmaceuticals, Inc.
PHAT
Type
Purchase
Shares
12,919
Price
$7.82
Value
$101K
Myovant Sciences Ltd.
MYOV
Type
Disposition
Shares
21,096
Price
-
Value
-
AI Agent

Try asking...

FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market